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Abstract
AIM: To investigate the histological features of the 
liver in spontaneously diabetic Torii (SDT) fatty rats 
compared with age-matched Sprague-Dawley (SD) 
rats.
METHODS: Female SDT Leprfa (SDT fatty) rats and 
age-matched SD rats were fed ad libitum. Body weight 
and biochemical parameters, such as serum glucose, 
triglyceride (TG), total cholesterol (TC), alanine 
aminotransferase (ALT) and aspartate aminotransferase 
(AST) levels as well as fatty acid and TG accumulation 
in the liver were evaluated at 8 wk of age in the non-
fasting state and at 8-wk intervals from 8 to 40 wk of 
age. Histopathological examinations of the liver were 
performed using hematoxylin and eosin and Sirius 
Red staining as well as double staining for ED-1 and 
toluidine blue. The expression of genes involved in TG 
synthesis, inflammation, and fibrosis was examined in 
the liver.
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Basic Study
Female spontaneously diabetic Torii fatty rats develop 
nonalcoholic steatohepatitis-like hepatic lesions 
and cirrhosis[2]. In Western countries, 4%-22% of 
NAFLD cases lead to hepatocellular carcinoma[3-6]. The 
pathogenesis of NASH remains poorly defined, and 
effective pharmacological therapies for NASH have not 
been approved.
To understand the complicated features of NAFLD/
NASH, animal models offer a source of important 
information. It has been reported that ob/ob mice, 
db/db mice, and KK-Ay mice, as NAFLD animal models, 
exhibit spontaneous hepatic steatosis based on insulin 
resistance and obesity, but these mice do not progress 
to liver fibrosis when fed a normal diet[7-9]. In contrast, 
methionine and choline-deficient (MCD) diet-induced 
NASH is accompanied by hepatic inflammation and 
fibrosis in ob/ob mice and db/db mice[10,11].
Spontaneously diabetic Torii Leprfa (SDT fatty) 
rats, which are generated by introducing the fa allele 
of the Zucker fatty rat into the SDT rat genome, 
represent a new model of obese type 2 diabetes. SDT 
fatty rats exhibit hyperphagia that leads to obesity 
associated with hyperglycemia, hyperinsulinemia, and 
hyperlipidemia at a young age compared with SDT 
rats[12,13]. Compared with SDT rats, this early onset of 
diabetes in SDT fatty rats is considered to be caused 
by obesity resulting from hyperphagia. Furthermore, 
female SDT rats also exhibit hyperglycemia at the 
same young age as male SDT fatty rats[14,15].
SDT fatty rats have been used to investigate the 
effects of a high-fat diet in a previous study. In this 
prior study, the rats fed a high-fat diet had improved 
hyperglycemia and increased serum glucagon-like 
peptide-1 (GLP-1) levels after refeeding[16]. Moreover, 
histopathological observations showed improvement 
in the fatty liver and pancreatic abnormalities. This 
previous report showed beneficial effects on diabetes 
in SDT fatty rats fed a high-fat diet. 
With regard to the metabolic responses to a high-
fat diet in Sprague-Dawley (SD) rats, steatohepatitis 
associated with hepatic fatty changes, inflammation, 
and mitochondrial lesions has been confirmed[17]. 
C57BL6 mice fed a high-fat diet also develop steato-
hepatitis[18]. However, the degree of hepatic fibrosis 
is less severe in animals fed a high-fat diet compared 
with choline-deficient diet models. 
In the present study, we investigated the histological 
features of the liver in SDT fatty rats without mani-
pulating the diet in comparison with age-matched SD 
rats. In addition to the pathophysiology, the biochemical 




This experiment was conducted in compliance 
with the Guidelines for Animal Experimentation of 
Japan Tobacco Biological/Pharmacological Research 
Laboratories. The animal protocol was designed to 
Ishii Y et al . New NASH-like animal model
9068 August 14, 2015|Volume 21|Issue 30|WJG|www.wjgnet.com
RESULTS: SDT fatty rats showed significantly increased 
body weight compared with SD rats. Serum glucose, 
TG, and TC levels were significantly higher in SDT fatty 
rats compared with SD rats. The serum AST and ALT 
levels in SDT fatty rats were significantly elevated at 8 
wk of age compared with the levels in SD rats. Hepatic 
TG content was marked in SDT fatty rats from 8 to 32 
wk of age. Histopathologically, severe hepatosteatosis 
accompanied by inflammation was observed at 8 
wk of age, and fibrosis started to occur at 32 wk of 
age. Furthermore, Sirius Red and ED-1 staining were 
increased in the liver at 32 wk of age. Hepatic gene 
expression related to TG synthesis, inflammation and 
fibrosis tended to increase in SDT fatty rats compared 
with SD rats, and the gene expression related to TG 
secretion was decreased in SDT fatty rats compared 
with SD rats. 
CONCLUSION: Female SDT fatty rats have the potential 
to become an important animal model of nonalcoholic 
steatohepatitis with type 2 diabetes and obesity.
Key words: Nonalcoholic steatohepatitis; Spontaneously 
diabetic Torii fatty rat; Fibrosis; Fatty liver; Metabolic 
syndrome 
© The Author(s) 2015. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: Nonalcoholic steatohepatitis (NASH) is 
recognized as a major risk for progression to cirrhosis 
and liver failure or to hepatocellular carcinoma. In this 
study, we investigated the histological features of the 
liver in female spontaneously diabetic Torii (SDT) fatty 
rats. The SDT fatty rats exhibited pathophysiological 
features of NASH, and fibrosis appeared in the liver 
without dietary manipulation. Female SDT fatty rats 
have the potential to become an important animal 
model of NASH with type 2 diabetes and obesity, a 
condition for which few models currently exist.
Ishii Y, Motohashi Y, Muramatsu M, Katsuda Y, Miyajima 
K, Sasase T, Yamada T, Matsui T, Kume S, Ohta T. Female 
spontaneously diabetic Torii fatty rats develop nonalcoholic 
steatohepatitis-like hepatic lesions. World J Gastroenterol 2015; 
21(30): 9067-9078  Available from: URL: http://www.wjgnet.
com/1007-9327/full/v21/i30/9067.htm  DOI: http://dx.doi.
org/10.3748/wjg.v21.i30.9067
INTRODUCTION
Nonalcoholic fatty liver disease (NAFLD) is presently 
well recognized as the most common chronic liver 
disease in the Western world[1]. NAFLD is strongly 
associated with central obesity, type 2 diabetes, 
dyslipidemia, hypertension, and insulin resistance[1]. 
NAFLD represents the pathology of fatty liver, including 
simple steatosis, nonalcoholic steatohepatitis (NASH), 
minimize pain or discomfort to the animals. Female 
SDT fatty rats from our colony were used in the study. 
At 8 wk of age, SDT fatty rats were divided into 5 
groups for necropsy at 8, 16, 24, 32, and 40 wk of 
age. SD rats [Crj: CD (SD); Charles River Japan, 
Yokohama, Japan], as control animals, at 8 wk of age 
were also divided into the same 5 groups as the SDT 
fatty rats. In the experimental period, one SDT fatty rat 
in the 24-wk necropsy group died due to unidentified 
causes, leaving 4 animals in this group. The rats were 
housed individually in suspended bracket cages in a 
climate-controlled room with a temperature of 23 ℃ 
± 3 ℃, humidity 55% ± 15%, and a 12-h dark-light 
cycle, and the rats had free access to a commercial 
diet (CRF-1, Charles River Japan, Yokohama, Japan) 
and water. The rats were anesthetized with isoflurane 
inhalation before the procedures.
Biological parameters
Body weight and biochemical parameters, such as 
serum glucose, triglyceride (TG), total cholesterol 
(TC), alanine aminotransferase (ALT), and aspartate 
aminotransferase (AST) levels, were measured at 8 
wk of age and thereafter at 8-wk intervals until 40 
wk of age. Blood samples were collected from the tail 
vein of the rats. The samples were stored in ice water 
until measurement. Serum glucose, TG, TC, ALT, and 
AST levels were measured as biochemical parameters 
using commercial kits (Roche Diagnostics, Basel, 
Switzerland) in an automatic analyzer (Hitachi 7170S; 
Hitachi, Tokyo, Japan). 
Tissue sampling and histopathology
Necropsy was performed at 8, 16, 24, 32, and 
40 wk of age (n = 5 for each age, except 24 wk 
of age with n = 4). All animals were sacrificed by 
exsanguination under isoflurane anesthesia. The livers 
were sampled for measurement of gene expression, 
hepatic lipid content, and histopathology. Samples 
for determination of gene expression and hepatic 
lipid content were stored at -80 ℃ until analysis. For 
histopathology, the livers were immediately fixed in 
10% neutral-buffered formalin. After resection, the 
tissue was paraffin-embedded by standard techniques 
and sectioned (3 to 5 µm). The sections were stained 
with hematoxylin and eosin (HE). The samples were 
all examined histopathologically in a blind manner, and 
the findings were graded from normal (-) to severe 
(3+).
Immunostaining
The paraffin-embedded tissue sections were also 
stained with Sirius Red and toluidine blue (TB), and 
immunohistochemistry was performed for ED-1 
(CD68: 1:100, BMA BIOMEDICALS, Switzerland) and 
alpha-smooth muscle actin (α-SMA; 1A4, 1:50, Dako, 
Denmark).
Hepatic TG and FFA content
An approximate 100 mg portion of the liver, 0.5 
mL of methanol, and zirconia beads were added 
to tubes. The liver portion was homogenized using 
a mixer mill (MM300 Retch) (25 Hz for 10 min). 
To the homogenized solution, 1 mL of chloroform 
was added and mixed thoroughly. The mixture was 
then centrifuged (10000 g for 5 min at 4 ℃), and 
the resultant supernatant was collected. Solvents 
contained in 0.5 mL of the supernatant were dried 
under a stream of nitrogen gas. To the residue, 0.5 mL 
of 2-propanol was added, and the residue was then 
dissolved again. The TG concentration of the 2-propanol 
solution was determined using the biochemistry 
automatic analyzer (Hitachi 7170S; Hitachi, Tokyo, 
Japan). The free fatty acid (FFA) concentration was 
analyzed using a NEFA-C kit (Wako Pure Chemical 
Industries, Ltd., Osaka, Japan).
mRNA quantification with real-time quantitative PCR
Total RNA was extracted from the liver with the 
GenElute Mammalian Total RNA Miniprep Kit (Sigma-
Aldrich, St. Louis, MO, United States) at 8, 16, 24, 
32, and 40 wk of age. RNA was transcribed into cDNA 
using M-MLV reverse transcriptase and random primers 
(Invitrogen, Carlsbad, CA, United States). The reaction 
mixture was incubated for 10 min at 25 ℃, 1 h at 
37 ℃, and 5 min at 95 ℃. Real-time PCR quantification 
was performed in a 50 µL reaction mixture with an 
automated sequence detector combined with ABI Prism 
7700 Sequence Detection System software (Applied 
Biosystems, Foster City, CA, United States). The 
reaction mixture contained 50 ng of synthesized cDNA, 
3.5 mmol/L MgCl2, 0.3 µmol/L primers, 0.1 µmol/L 
probes, and 1.25 units of Ampli Taq Gold®. The cycle 
parameters included 10 min at 95 ℃ followed by 40 
cycles of 15 s at 95 ℃ and 60 s at 60 ℃. The following 
primers and FAM-conjugated probes were designed 
using Primer Express software (Applied Biosystems): 
SREBP-1c (forward, CGACTACATCCGCTTCTTACAGC; 
reverse, TTTTGTGAGCACTTCGCAGG; probe, 
CAGCAACCAGAAACTCAAGCAGGAGAACC), DGAT2 
(forward, GCTGATAGCTGCTCTCTACTTCACC; 
reverse, TGTGATCTCCTGCCACCTTTCT; probe, 
T G G C ATTT G A C T G G A A C A C G C C C A ) ,  FA S 
( f o rward ,  ACTGAACGGCATTACTCGGTCC; 
reverse, GTGTCCCATGTTGGATTTGGTG; probe, 
TTCCGCCAGAGCCCTTTGTTAATTGG) ,  MTP 
( fo rward ,  GGACGTTGTGTTACTGTGGAGG; 
reverse, ACATTGACAGCCGTTATCGTGA; probe, 
GATCCCGACGGTGACGATGATCAACTG), and β-actin 
(purchased from Applied Biosystems). The expression 
of the following genes were confirmed using 
Taqman Gene Expression Assays on Demand and 
Universal Maser Mix: ACC (Rn00573474_m1), α-SMA 
(Rn01759928_g1), MCP-1 (Rn00580555_m1), TGF-β 
(Rn99999016_m1), TNF-α (Rn99999017_m1), and 
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rats at 32 wk of age.
Fibrosis was also confirmed by Sirius Red staining 
(Figure 3A-D). Consistent with the HE staining, similar 
findings of fibrosis were observed in SDT fatty rats. 
However, these changes were not observed in SD rats 
(Table 1). Activated hepatic stellate cells (HSCs) in the 
liver were investigated by α-SMA immunostaining. The 
SD rats showed few HSCs at 32 wk of age. Consistent 
with the presence of hepatic fibrosis, there were 
increased numbers of α-SMA-positive, activated HSCs 
in SDT fatty rats (Figure 3E and F). To examine the 
macrophages and mast cells in the liver, liver sections 
were immunostained with ED-1 and TB. Increased 
macrophage and mast cell counts, as indicated by 
ED-1- and TB-positive stained cells, respectively, were 
found in SDT fatty rats at 32 wk of age, and these cells 
were scarcely observed in SD rats (Figure 3G and H).
Liver mRNA expression 
The mRNA levels of lipogenic genes (SREBP-1c, FAS, 
ACC, DGAT2, and MTP), inflammatory genes (MCP-1 
and TNF-α), and fibrotic genes (collagen Type 1, 
TGF-β , and α-SMA) in the liver were measured by 
real-time PCR at 8-wk intervals. At 8 wk of age, the 
expression of lipogenic genes (such as SREBP-1c, FAS, 
and ACC) increased in SDT fatty rats compared with 
SD rats (Figure 4A-C). The DGAT2 mRNA level was not 
increased in SDT fatty rats (Figure 4D), and the MTP 
mRNA level, which is related to secretion of very low-
density lipoprotein (VLDL), was decreased by 64% 
in SDT fatty rats compared with SD rats (Figure 4E). 
After 16 wk of age, SDT fatty rats showed decreased 
expression of lipogenic genes (such as SREBP-1c, 
FAS, and ACC). The expression of lipogenic genes was 
comparable between SDT fatty rats and SD rats, but 
the DGAT2 and MTP mRNA levels in SDT fatty rats 
were lower than those in SD rats.
The TNF-α and MCP-1 inflammatory genes were 
increased by 16.1% and 38.9%, respectively, in SDT 
fatty rats at 16 wk of age (Figure 4F and G). The 
mRNA levels of fibrotic genes, namely collagen type 
1 and α-SMA, tended to increase in SDT fatty rats 
compared with SD rats at 16 and 24 wk of age. The 
TGF-β mRNA levels in SDT fatty rats also tended to 
increase at 32 wk of age.
DISCUSSION
In a previous study, we investigated diabetes mellitus 
in female SDT fatty rats by comparing these rats 
with age-matched female SDT rats. Female SDT 
fatty rats showed metabolic abnormalities such as 
hyperglycemia, hyperinsulinemia, and dyslipidemia at 
a young age, which were similar to the abnormalities 
observed in male SDT fatty rats[14]. Furthermore, 
diabetic complications such as renal lesion and 
cataracts were observed at 16 wk of age in female SDT 
fatty rats, and were comparable to the complications 
collagen type 1 (Rn01463848_m1).
Statistical analysis
The results of the biological parameters are expressed 
as the mean ± SD. Statistical analysis of differences 
between mean values was performed using an F-test 
followed by the Student t-test or the Aspin-Welch t-test. 
Differences were considered significant at P < 0.05. 
The statistical methods of this study were reviewed by 
Dr. Hisayo Morinaga from Biological/Pharmacological 
research laboratories, Central Pharmaceutical Research 
Institute, Japan Tobacco Inc.
RESULTS
Body weight and biochemical parameters
SDT fatty rats showed obesity at 8 wk of age. The 
mean bodyweight at 8 wk was significantly higher in 
SDT fatty rats compared with SD rats (328 ± 40 g vs 
216 ± 8 g; P < 0.01). Obesity was sustained in SDT 
fatty rats until 24 wk of age (Figure 1A). The serum 
glucose levels in SDT fatty rats were higher than 
those in SD rats at 8 wk of age, and the increase was 
sustained until 40 wk of age (Figure 1B). The serum 
TG levels in SDT fatty rats increased until 24 wk of 
age, and they slightly decreased after 32 wk (Figure 
1C). The serum TC levels in SDT fatty rats increased 
throughout the observation period (Figure 1D). The 
serum TG and TC levels in SDT fatty rats were higher 
than those in SD rats until 40 wk of age. Furthermore, 
the serum AST and ALT levels were significantly 
elevated at 8 wk, and these high levels were sustained 
until 40 wk of age (Figure 1E and F). 
Liver weight and hepatic TG and FFA content
The liver weights were increased in SDT fatty rats until 
24 wk of age and slightly decreased thereafter, but 
they were greater than those in SD rats throughout 
the experiment, except at 24 wk of age (Figure 2A). 
The hepatic TG content in SDT fatty rats was higher 
than that in SD rats at 8 wk of age (129 ± 77 mg/g 
tissue vs 10 ± 2 mg/g tissue; P < 0.01). The hepatic 
TG content was markedly elevated until 16 wk of 
age in SDT fatty rats, and gradually decreased to the 
level in SD rats (Figure 2B). The hepatic FFA content 
showed a similar change to hepatic TG content in 
SDT fatty rats because it increased until 16 wk and 
gradually decreased after 32 wk of age (Figure 2C). 
Histopathological analyses
The liver histopathology was examined by HE staining. 
Histopathologically, severe changes (3+) of the liver, 
including fatty and vacuolar changes, were observed 
in SDT fatty rats at 8 wk of age. Moderate changes 
(1+-2+) of hypertrophy and very slight or slight 
changes in inflammation were also observed in SDT 
fatty rats at 8 wk of age (Table 1). Moreover, moderate 
changes (2+) indicating fibrosis were observed in SDT 
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observed in male SDT fatty rats[15]. Sexual differences 
in SDT fatty rats did not exist in the progression of 
diabetes. Thus, female SDT fatty rats are an important 
animal model of metabolic syndrome with diabetes 
In Zucker diabetic fatty rats, hepatic steatosis is 
observed without dietary manipulation, but hepatic 
fibrosis is not observed[19]. Although ob/ob and 
db/db mice develop hepatic steatosis associated 
with obesity and insulin resistance, these mice do 
not spontaneously progress to significant steato-
hepatitis[8,9]. Ob/ob and db/db mice show significant 
steatohepatitis development when fed a MCD diet, 
but only db/db mice fed a MCD diet have increased 
fibrosis in the liver[10,11]. Db/db mice require other 
stimulation in addition to the background condition, 
such as obesity, diabetes, and dyslipidemia, to trigger 
progression to fibrosis[10]. 
In the present study, we investigated the patho-
physiological changes of the liver in female SDT fatty 
rats compared with SD rats. We used SD rats as the 
control, instead of SDT rats, because we wanted 
to focus on the investigation of pathophysiological 
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Figure 1  Changes in body weight and biological parameters in spontaneously diabetic Torii fatty rats and Sprague-Dawley rats. A: Body weight; B: Glucose; 
C: Triglyceride; D: Total cholesterol; E: Alanine aminotransferase; F: Aspartate aminotransferase. Data are shown as mean ± SD (n = 4-5). aP < 0.05, bP < 0.01, vs 
Sprague-Dawley rats. SDT: spontaneously diabetic Torii; SD: Sprague-Dawley.
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Figure 2  Changes in liver weight, hepatic triglyceride, and fatty acid contents in Spontaneously Diabetic Torii fatty rats and Sprague-Dawley rats. A: Liver 
weight; B: Hepatic triglyceride content; C: Hepatic fatty acid content. Data are shown as the mean ± SD (n = 4-5). Data are shown as the mean ± SD (n = 4-5). aP < 0.05, 
bP < 0.01, vs SD rats. FFA: Free fatty acid; TG: Triglyceride.
A B
C
Table 1  Microscopy findings of the liver in female spontaneously diabetic Torii fatty rats and Sprague-Dawley rats
8 wk 16 wk 24 wk 32 wk 40 wk
SD SDT fatty SD SDT fatty SD SDT fatty SD SDT fatty SD SDT fatty
Hepatosteatosis (Vacuolar change/fatty change)
   - 5 0 5 0 5 0 5 0 5 0
   ± 0 0 0 0 0 0 0 0 0 0
   + 0 0 0 0 0 0 0 0 0 0
   2+ 0 4 0 2 0 2 0 3 0 3
   3+ 0 1 0 3 0 2 0 2 0 2
Hypertrophy of hepatocytes (with vacuolation/fatty change)
   - 5 1 5 0 5 0 5 0 5 1
   ± 0 0 0 0 0 0 0 0 0 0
   + 0 2 0 2 0 2 0 1 0 2
   2+ 0 2 0 3 0 2 0 3 0 1
   3+ 0 0 0 0 0 0 0 1 0 1
Fibrosis, focal
   - 5 4 5 5 5 4 5 1 5 1
   ± 0 0 0 0 0 0 0 0 0 0
   + 0 1 0 0 0 0 0 1 0 2
   2+ 0 0 0 0 0 0 0 3 0 2
   3+ 0 0 0 0 0 0 0 0 0 0
Infiltration, inflammatory cell, periportal
   - 5 2 5 4 5 3 5 3 5 3
   ± 0 3 0 1 0 1 0 0 0 1
   + 0 0 0 0 0 0 0 2 0 1
   2+ 0 0 0 0 0 0 0 0 0 0
   3+ 0 0 0 0 0 0 0 0 0 0
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changes of the liver in SDT fatty rats. In our previous 
study, we confirmed that female SDT rats only exhibit 
a fatty liver based on histopathology[16] but not fibrosis 
at 40 wk of age. Furthermore, male SDT rats, which 
are a severe type 2 diabetic model, do not exhibit a 
fatty liver and liver fibrosis at 24 wk of age[20].
SDT fatty rats showed hyperglycemia associated 
with increased body weight at 6 wk of age, and they 
exhibited severe hyperglycemia after 6 wk of age, 
which is considered to be due to a decrease in insulin 









Figure 3  Liver histopathology at 40 wk of age. A, C, E, G: SD rats; B, D, F, H: SDT fatty rats. A, B: Hematoxylin and eosin (HE); C, D: Sirius Red; E, F: Alpha-
smooth muscle actin (α-SMA); G, H: Toluidine blue staining and immunohistochemistry for ED-1. 
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levels. Indeed, our previous study has shown that 
insulin levels in SDT fatty rats increase until 6 wk of 
age and gradually decease thereafter, but the levels 
are significantly higher than those in SD rats until 20 
wk of age (8.89 ± 7.07 ng/mL vs 1.42 ± 0.49 ng/mL; P 
< 0.05). From 20 to 40 wk of age, the insulin levels 
in SDT fatty rats are slightly greater than those in 
SD rats[14]. As expected, the hepatic TG content in 
SDT fatty rats was higher than those of SD rats, 
and it peaked at 16 wk of age. After 16 wk of age, 
it gradually decreased to the levels observed in the 
SD rats. The mRNA expression levels of MCP-1 and 
TNF-α at 16 wk of age were increased, suggesting 
that SDT fatty rats had accelerated liver injury and 
inflammation. The mRNA expression of collagen type 
1 and α-SMA tended to increase in SDT fatty rats. 
With regard to the pathophysiology, hepatic fibrosis 
was observed in SDT fatty rats at 32 wk of age. 
These findings indicated that female SDT fatty rats 
spontaneously develop nonalcoholic steatohepatitis-
like hepatic lesions without dietary manipulation.
The hepatic steatosis in SDT fatty rats observed 
at 8 wk of age resulted from increased hepatic 
TG synthesis and decreased VLDL secretion, and 
histopathological findings, such as fatty changes in 
the hepatocytes, showed hepatic steatosis. Indeed, 
the hepatic FFA content, which is a component of TG, 
was also increased. The expression of genes related 
to lipogenesis, FAS, and ACC1 was increased, and the 
expression of MTP, which is a gene related to VLDL 
secretion, was decreased in SDT fatty rats at 8 wk of 
age. Furthermore, the FFA content in the liver was 
attributed to the degradation of serum lipoproteins and 
uptake of serum FFA. The hyperlipidemia in SDT fatty 
rats is considered to supply fatty acids to the liver. 
In terms of the hepatic steatosis, SDT fatty rats are 
comparable to other rat strains at 8 wk of age[19,21]. 
In contrast, the decrease in the hepatic TG content 
after 24 wk of age may be based on the decreased 
de novo lipogenesis. The mRNA expression of SREBP-
1c, which regulates FAS and ACC1 mRNA expression, 
was decreased in SDT fatty rats after 16 wk of age. 
Some complex mechanisms involved in the decrease 
in SREBP-1c mRNA expression of liver should be 
considered. It is known that insulin activates the 
SREBP-1c promoter in liver, thereby increasing fatty 
acid and triglyceride synthesis[22]. A previous study 
has shown that the serum insulin levels are decreased 
in SDT fatty rats after 6 wk of age[14,16]. The reduction 
of SREBP-1c levels could contribute to the decrease 
in serum insulin levels. The reduction of hepatic 
steatosis has also been shown in Otsuka Long-Evans 
Tokushima fatty rats after 30 wk of age[21]. The change 
in hepatic steatosis is considered to be associated with 
a decrease in SREBP-1c expression[23]. The change 
in hepatic steatosis in SDT fatty rats may be partly 
due to decreased SREBP-1c expression based on 
the decreased serum insulin levels. Further study is 
required to confirm this mechanism.
The spontaneous development of steatohepatitis 
and hepatic fibrosis in SDT fatty rats could be 
explained by the increase in hepatic FFA. The excess 
FFA could serve as precursors for the production 
of lipid peroxidation[24], which can activate hepatic 
stellate cells and thereby result in the development of 
fibrosis[25,26]. Indeed, an increase in α-SMA level, which 
is an indicator of activated hepatic stellate cells, was 
observed. In addition to lipid peroxidation, CYP2E1 
may be involved in hepatic fibrosis development in 
SDT fatty rats. It has been reported that fatty acids 
increase both CYP2E1 mRNA and protein levels in the 
liver of high-fat diet fed animals[27]. CYP2E1 produces 
high levels of reactive oxygen species[28,29], which play 
an important role in the development of NASH and 
fibrosis[30].
The difference in the pathophysiology of the liver 
between SDT fatty rats and other diabetic animal 
models remains unknown. However, the hepatic 
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Figure 4  Expression of genes related to triglyceride synthesis, triglyceride secretion, inflammation, and fibrosis in spontaneously diabetic Torii fatty rats 
and SD rats. A: SREBP-1c; B: FAS; C: ACC; D: DGAT2; E: MTP; F: TNF-α; G: MCP-1; H: Collagen type 1; I: α-SMA; J: TGF-β. Data are shown as the mean ± SD (n 
= 4-5). aP < 0.05, bP < 0.01, vs SD rats. SDT: Spontaneously diabetic Torii; SD: Sprague-Dawley.
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vulnerability in SDT fatty rats could be explained by 
the sensitivity to inflammation. SDT rats, which are the 
strain of origin of SDT fatty rats, show hyperglycemia 
caused by age-dependent degenerative changes in 
pancreatic islets[31,32]. Treatment with telmisartan 
ameliorates hyperglycemia and hypoinsulinemia 
due to the reduction in oxidative stress caused by 
renin angiotensin system activation in SDT rats[33], 
suggesting that a large amount of NO is produced by 
macrophages in the islets[34]. It has been suggested 
that SDT rats are under inflammatory conditions 
physiologically. In SDT fatty rats, ED-1 staining, which 
is a marker for activated macrophages, was increased 
in the liver at 40 wk of age. These results suggested 
that SDT fatty rats have increased inflammation as a 
steady condition in the liver. This state may enhance 
the stress sensitivity caused by lipid peroxidation, 
which induces hepatic fibrosis. Further study is needed 
to clarify the hepatic characteristics of SDT fatty rats. 
In addition, it is necessary to investigate whether SDT 
fatty rats develop hepatocarcinoma after 40 wk of age. 
Compared with human NASH, SDT fatty rats 
have steatohepatitis accompanied by metabolic 
syndrome, including hyperglycemia, hyperinsulinemia, 
and obesity, which are similar features to those of 
human NASH. Human NASH is strongly associated 
with obesity, type 2 diabetes, and dyslipidemia[35,36]. 
In contrast, there is a difference between SDT fatty 
rats and human NASH. Pathophysiological features of 
NASH with fibrosis are observed in only female SDT 
fatty rats and not in male SDT fatty rats. Meanwhile, 
the prevalence of human NASH is common in men 
rather than women, which might be explained by sex 
hormones[37]. Further studies are needed to examine 
the molecular basis of this sex difference in SDT fatty 
rats.
In conclusion, female SDT fatty rats showed 
steatohepatitis (e.g., increased plasma ALT and hepatic 
steatosis) associated with hyperglycemia and dyslipidemia 
at 8 wk of age. Thereafter, hepatic fibrosis began to be 
observed at 32 wk of age. These results demonstrated 
that female SDT fatty rats exhibit pathophysiological 
features of NASH in the absence of dietary manipulation. 
The precise mechanisms for developing NASH in humans 
remain unknown. However, female SDT fatty rats have 
the potential to become an important animal model of 
NASH with type 2 diabetes and obesity, a condition for 
which few models currently exist.
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Obesity and type 2 diabetes are well established risk factors for many chronic 
disorders, such as non-alcoholic steatohepatitis (NASH). Approximately 5%-10% 
of NASH patients are diagnosed with cirrhosis and/or hepatocellular carcinoma 
within 10 to 20 years. Currently, no medicines are approved for the treatment 
of NASH. To understand the complicated features of the disease, animal 
models of non-alcoholic fatty liver disease (NAFLD) offer important information 
for therapeutic intervention. Currently, there are no animal models of NASH 
accompanied by essential features of clinical conditions, such as obesity and 
insulin resistance, without dietary manipulation. 
Research frontiers
Spontaneously diabetic Torii Leprfa (SDT fatty) rats show several metabolic 
syndrome features, including obesity, hyperglycemia, hyperlipidemia, and 
insulin resistance. However, the features of liver lesions in SDT fatty rats 
have not been reported in detail. In the present study, the pathophysiological 
changes in the liver of SDT fatty rats were examined over time. 
Innovations and breakthroughs
Many NASH studies have used animal models, such as diet-induced NASH 
models or mutant gene models, and these NASH animal models spontaneously 
progress to significant steatohepatitis accompanied by metabolic syndrome. 
This is the first study to show the time course of pathophysiological changes in 
the liver of SDT fatty rats. Furthermore, the in vivo studies suggest that female 
SDT fatty rats exhibit pathophysiological features of NASH in the absence of 
dietary manipulation.
Applications
Female SDT fatty rats may be useful to identify the complicated molecular 
mechanisms of the disease. In addition, this model may be a suitable preclinical 
model to evaluate candidate drugs for NASH.
Terminology
NAFLD is presently well recognized as the most common chronic liver disease 
in the Western world. NAFLD is a broad-spectrum liver disease that ranges from 
simple steatosis to NASH and cirrhosis. Approximately 20%-30% of NALFD 
patients progress to NASH. Because NASH leads to serious diseases, such 
as cirrhosis of the liver and hepatocarcinoma, the development of therapeutic 
agents is desirable. The pathogenesis of NASH remains poorly defined, and 
effective pharmacological therapies have not been approved.
Peer-review
This is a good study in which the authors examined the pathophysiological 
changes in the liver of SDT fatty rats over time. The results are interesting and 
suggest that female SDT fatty rats spontaneously exhibit pathophysiological 
features of NASH. Female SDT fatty rats have the potential to become a 
suitable preclinical model of NASH.
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